Related Experiment Video
Updated: Feb 8, 2026

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
Published on: July 16, 2020
Multi-resistant Pseudomonas aeruginosa ST235 in cystic fibrosis
Annabelle C Lee1, Andrew L Jones1
1Department of Cystic Fibrosis, Royal Brompton & Harefield Foundation NHS Trust, United Kingdom.
Abstract:
Chronic Pseudomonas aeruginosa infection is associated with a decline in lung function and overall poorer prognosis in the cystic fibrosis population. Molecular typing of P. aeruginosa has identified multiple clonal strains with increased virulence and transmissibility. P. aeruginosa ST235 is an emerging clonal strain with multi-drug resistance and is associated with more virulent infections. Novel cephalosporins, which have recently been introduced to clinical practice, may have higher efficacy against multi-drug resistant bacteria.
Insights
Chronic Pseudomonas aeruginosa infection impacts cystic fibrosis patients. Emerging multi-drug resistant strains like ST235 pose challenges, but novel cephalosporins show promise for treatment.
Area of Science:
- Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Chronic Pseudomonas aeruginosa infection is a major factor in cystic fibrosis (CF) patient decline.
- Specific hypervirulent and transmissible clonal strains of P. aeruginosa have been identified.
- The ST235 strain of P. aeruginosa is an emerging multi-drug resistant (MDR) pathogen linked to severe infections.
Purpose of the Study:
- To investigate the challenges posed by emerging MDR P. aeruginosa strains in CF.
- To evaluate the potential efficacy of novel cephalosporins against MDR P. aeruginosa.
Main Methods:
- Review of current literature on P. aeruginosa clonal strains in CF.
- Analysis of P. aeruginosa ST235 characteristics, including multi-drug resistance.
- Assessment of novel cephalosporin activity against MDR bacteria.
Main Results:
- P. aeruginosa ST235 exhibits multi-drug resistance and increased virulence.
- Novel cephalosporins demonstrate potential for treating infections caused by MDR bacteria.
Conclusions:
- Effective treatment strategies are needed for chronic P. aeruginosa infections in CF.
- Novel cephalosporins represent a promising therapeutic option against MDR P. aeruginosa strains like ST235.
More Related Videos
11:20Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
Published on: May 12, 2020
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Resistivity
Resistance
Equivalent Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...